Streetbeat News

Regulatory

AMZN

DIS

NFLX

SONY

The $8.5 billion merger between Walt Disney Co. and India's Reliance Industries media assets faces antitrust concerns from the Indian regulator over cricket broadcasting rights. The companies are exploring remedies but are reluctant to part with these rights, which are crucial for the merger's success.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:16 pm

NVAX

Novavax is collaborating with the U.S. FDA to secure authorization for its 2024-2025 formula Covid-19 vaccine. The company anticipates receiving approval in time for the peak vaccination season.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:04 pm

BTCUSD

Jerome Powell is expected to signal a shift towards easing monetary policy at the Jackson Hole Economic Symposium, with a 25 basis point rate cut anticipated in September. This has kept U.S. financial markets buoyant, but Bitcoin remains below its all-time high despite positive crypto developments.

Portfolio Pulse from Murtuza Merchant

August 22, 2024 | 5:58 pm

BIIB

Biogen's Alzheimer's drug, Leqembi, has been approved by the UK's Medicines and Healthcare products Regulatory Agency. However, the National Institute for Health and Care Excellence (NICE) does not recommend it for NHS reimbursement due to cost-effectiveness concerns. Despite showing a small benefit in slowing disease progression, the drug's high costs and limited long-term evidence are barriers.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 5:45 pm

MRNA

PFE

The FDA has authorized updated Covid-19 vaccines developed by Moderna and Pfizer. This decision is expected to impact the stock prices of both companies as they prepare to distribute the new vaccines.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 5:30 pm

TPG

TPG has agreed to sell PS, an operator of private luxury terminals, to Groupe ADP. The transaction is pending regulatory approvals, and terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 5:22 pm

SPY

Investors are closely watching Fed Chair Jerome Powell's upcoming speech at the Jackson Hole Symposium for hints on monetary policy. While a rate cut in September is expected, the size of the cut remains uncertain. Analysts predict Powell may express confidence in the inflation outlook and emphasize labor market risks. The SPDR S&P 500 ETF Trust (NYSE:SPY) could be impacted by Powell's guidance, as seen in past reactions to his speeches.

Portfolio Pulse from Piero Cingari

August 22, 2024 | 5:09 pm

CMND

Clearmind Medicine's shares rose following the announcement of a patent approval from the US Patent and Trademark Office.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 5:05 pm